Douglas Scharre

Director, Division of Cognitive Neurology, Department of Neurology

Ohio State University, Wexner Medical Centre

Douglas Scharre

Dr. Douglas W. Scharre is the Director, Division of Cognitive Neurology and the Medical Director of The Ohio State University Center for Cognitive and Memory Disorders. He is a clinical researcher and behavioral neurologist specializing in the diagnosis and management of cognitive issues for over 20 years. He has conducted or participated in over 140 clinical research studies in dementia and mild cognitive impairment, funded by NIH, foundations and industry, utilizing neuroimaging (anatomical and functional (resting and task-activated) MRI, PET, and SPECT), serum and cerebrospinal fluid biomarkers, cognitive biomarkers, genetic biomarkers, and cognitive, functional, and behavioral scales on dementia and control subjects. He has designed and developed both paper and digital versions of the Self-Administered Gerocognitive Examination (SAGE), a cognitive assessment instrument designed for identifying individuals in a practical way with mild cognitive impairment or early dementia from any cause and to be sensitive to changes over time. He lectures frequently on topics of dementia, Alzheimer’s disease, behavioral management of dementia and other aspects of cognitive neurology. Dr. Scharre joined The Ohio State University Wexner Medical Center faculty in the Department of Neurology in 1993. Dr. Scharre is board certified in neurology and in behavioral neurology and neuropsychiatry with special interests in cognitive assessment, degenerative dementias and dementia-related behaviors.

Follow Douglas Scharre' at upcoming/ongoing conferences at gtcbio:

Neurological Biomarkers